Masami Hirano

Treatment of adult T-cell leukemia/lymphoma with MST-16, a new oral antitumor drug and a derivative of bis(2,6-dioxopiperazine)

Ryuzo Ohno, T Masaoka, Shigeru Shirakawa et al. · Cancer · 1993 · 49 citations

Medicine, Oncology, Pharmacology +16

Acute leukemia with the phenotype of a natural killer/T cell bipotential precursor

T Ino, Motohiro Tsuzuki, Masataka Okamoto et al. · Annals of Hematology · 1999 · 20 citations

Life Sciences, Hematology, Oncology +13

Treatment of Myelodysplastic Syndromes with Orally Administered l-β-Z)-Arabinofuranosylcytosine-5’-Stearylphosphate

Ryuzo Ohno, Noriyuki Tatsumi, Masami Hirano et al. · Oncology · 2009 · 19 citations

Medicine, Pharmacology, Pharmacotherapy +17